Schellekens Kh
About
In The Last Decade
Schellekens Kh
10 papers receiving 701 citations
Peers
Comparison fields: 5 of 88
- Cellular and Molecular Neuroscience 410
- Molecular Biology 224
- Psychiatry and Mental health 146
- Physiology 95
- Cognitive Neuroscience 94
Countries citing papers authored by Schellekens Kh
This map shows the geographic impact of Schellekens Kh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schellekens Kh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schellekens Kh more than expected).
Fields of papers citing papers by Schellekens Kh
This network shows the impact of papers produced by Schellekens Kh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schellekens Kh. The network helps show where Schellekens Kh may publish in the future.
Co-authorship network of co-authors of Schellekens Kh
This figure shows the co-authorship network connecting the top 25 collaborators of Schellekens Kh. A scholar is included among the top collaborators of Schellekens Kh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Schellekens Kh. Schellekens Kh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting. | 49 |
| 2 | Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs. | 76 |
| 3 | Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series. | 2 |
| 4 | Bezitramide (R 4845), a new potent and orally long-acting analgesic compound. | 13 |
| 5 | The pharmacology of fluspirilene (R 6218), a potent, long-acting and injectable neuroleptic drug. | 23 |
| 6 | Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine. | 152 |
| 7 | Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? | 112 |
| 8 | IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS. | 298 |
| 9 | The pharmacology of dehydrobenzperidol, a new potent and short acting neuroleptic agent chemically related to Haloperidol. | 51 |
| 10 | Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. III. Duration of antiemetic action and oral effectiveness of Haloperidol (R 1625) and of chlorpromazine in dogs. | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.